0001567619-20-001041.txt : 20200114 0001567619-20-001041.hdr.sgml : 20200114 20200114175030 ACCESSION NUMBER: 0001567619-20-001041 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200110 FILED AS OF DATE: 20200114 DATE AS OF CHANGE: 20200114 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Lanfear Dennis M CENTRAL INDEX KEY: 0001420822 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36721 FILM NUMBER: 20526839 MAIL ADDRESS: STREET 1: C/O INSMED INCORPORATED STREET 2: 8720 STONY POINT PKWY, SUITE 200 CITY: RICHMOND STATE: VA ZIP: 23235 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Coherus BioSciences, Inc. CENTRAL INDEX KEY: 0001512762 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 273615821 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: C/O DENNIS M. LANFEAR STREET 2: 333 TWIN DOLPHIN DR, SUITE 600 CITY: REDWOOD CITY STATE: CA ZIP: 94065 BUSINESS PHONE: (650) 649-3530 MAIL ADDRESS: STREET 1: C/O DENNIS M. LANFEAR STREET 2: 333 TWIN DOLPHIN DR, SUITE 600 CITY: REDWOOD CITY STATE: CA ZIP: 94065 FORMER COMPANY: FORMER CONFORMED NAME: BioGenerics, Inc. DATE OF NAME CHANGE: 20110210 4 1 doc1.xml FORM 4 X0306 4 2020-01-10 0 0001512762 Coherus BioSciences, Inc. CHRS 0001420822 Lanfear Dennis M COHERUS BIOSCIENCES, INC. 333 TWIN DOLPHIN DRIVE, SUITE 600 REDWOOD CITY CA 94065 1 1 0 0 President & CEO Common Stock, $0.0001 par value 2020-01-10 4 A 0 59763 0.00 A 184780 D Common Stock, $0.0001 par value 2020-01-10 4 F 0 21516 17.73 D 163264 D Common Stock, $0.0001 par value 446684 I By Trust Common Stock, $0.0001 par value 86965 I By LLC Stock Option (Right to Buy) 17.73 2020-01-10 4 A 0 500000 0.00 A 2030-01-10 Common Stock 500000 500000 D These shares are held by the Lanfear Revocable Trust, dated January 27, 2004, as restated, of which Reporting Person is a trustee. These shares are held by Lanfear Capital Advisors, LLC of which Reporting Person is President. The underlying shares subject to the option vest and become exercisable as to 1/48th of the total number of shares subject to the option in successive, equal monthly installments measured from January 1, 2020, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date. /s/ Jean-Frederic Viret, as Attorney-in-Fact for Dennis M. Lanfear 2020-01-14